Go to content
UR Home

Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA

URN to cite this document:
urn:nbn:de:bvb:355-epub-515345
DOI to cite this document:
10.5283/epub.51534
Drasch, Thomas ; Bach, Christian ; Luber, Markus ; Spriewald, Bernd ; Utpatel, Kirsten ; Büttner-Herold, Maike ; Banas, Bernhard ; Zecher, Daniel
[img]
Preview
License: Creative Commons Attribution 4.0
PDF - Published Version
(770kB)
Date of publication of this fulltext: 27 Jan 2022 15:15


Abstract

Background: It is still incompletely understood why some patients with preformed donor-specific anti-HLA antibodies (DSA) have reduced kidney allograft survival secondary to antibody-mediated rejection (ABMR), whereas many DSA-positive patients have favorable long-term outcomes. Elevated levels of soluble CD30 (sCD30) have emerged as a promising biomarker indicating deleterious T-cell help in ...

plus


Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de
0941 943 4239

Dissertations: dissertationen@ur.de
0941 943 3904

Research data: daten@ur.de
0941 943 4239

Contact persons